Clinical trial · Observational
Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function
Prospective Observational Study of Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function
NCT01650987CI-TRIAL-00023383SEXUTOXcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Corpus Uteri Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (6)
- label
- Col 1
- description
- Patient with uterus adenocarcinoma, treated by surgery, then surveillance without complementary treatment
- label
- Col 2
- description
- Patient with uterus adenocarcinoma, treated by surgery then adjuvant radiotherapy
- label
- Col 3
- description
- patient with uterus adenocarcinoma, treated by surgery then curietherapy of vaginal dome
- label
- Endometrial 4
- description
- patient with cervix carcinoma stage IA2 to IIB, treated by surgery only
- label
- endometrial 5
- description
- patient with cervix carcinoma stage IA2 to IIB, treated by surgery then curietherapy
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
* Inclusion Criteria: * Patients whose treatment is provided to Centre Oscar Lambret * With a corpus uteri adenocarcinoma, no metastatic, treated by: * Surgery and observation without complementary treatment * Or surgery and adjuvant radiotherapy * Or Surgery and curietherapy of vaginal dome * With a cervix carcinoma, stade IA2 to IIB proximal, treated by : * External radiochemotherapy and curietherapy * Or only surgery * Or pre-surgical curietherapy and surgery * Age \> 18 years
References
Publications (0)
Data not yet available
No reference posted for this study.